eGastroenterology

eGastroenterology is an open-access, open peer-reviewed journal launched in 2023 and published by BMJ Publishing Group on behalf of the First Hospital of Jilin University, covering gastroenterology, hepatology and related fields, and it carries a 2025 Journal Impact Factor of 10.5《数字胃肠病学》（eGastroenterology）是（BMJ Publishing Group）代表吉林大学第一医院于 2023 年创办的开放获取、开放同行评审期刊，覆盖胃肠病学、肝病学等相关领域，2025 年影响因子为 10.5。

Scope

• According to its official aims the journal dedicates itself to improving clinical diagnosis and treatment of gastrointestinal, hepatobiliary, pancreatic and esophageal diseases官方办刊宗旨显示，该刊致力于改善胃肠道、肝胆胰及食管疾病的临床诊断与治疗。
• Its main aim is to provide a platform for communication among researchers and clinicians engaged in basic, clinical and translational medicine research in gastroenterology and hepatology, with the ultimate goal of promoting the translation of basic science into clinical practice该刊主旨是为从事胃肠病学与肝病学基础、临床及转化医学研究的研究者与临床医生提供交流平台，最终目标是推动基础科学向临床实践转化。
• It publishes up-to-date research on prevention, diagnosis and treatment advances in all sub-fields of digestive medicine and surgery, accepting original research, reviews, short reports, guidelines, editorials and perspectives该刊发表消化内科与外科各分支领域预防、诊断及治疗进展的最新研究，接收原创研究、综述、简短报告、指南、社评与观点文章。
• Declared topics of interest include liver diseases such as viral hepatitis, MASLD/NAFLD, alcohol-related liver diseases and cholestatic and biliary diseases, hepatobiliary and pancreatic cancer, pancreas and esophageal diseases, hepato-pancreato-biliary surgery, translational gastroenterology and hepatology, and gastrointestinal disorders such as irritable bowel syndrome, gut microbiota, inflammatory bowel disease and gastrointestinal cancer官方选题涵盖病毒性肝炎、代谢功能障碍相关脂肪性肝病（MASLD/NAFLD）、酒精相关性肝病、胆汁淤积与胆道疾病等肝脏疾病，肝胆胰肿瘤，胰腺与食管疾病，肝胆胰外科，胃肠与肝病转化医学，以及肠易激综合征、肠道菌群、炎症性肠病与胃肠道肿瘤等消化系统疾病。
• Further listed topics span gastrointestinal endoscopy, gut immunity, nutrition, gastrointestinal surgery and epidemiology官方另列选题还包括胃肠道内镜、肠道免疫、营养、胃肠外科与流行病学。
• The journal applies an open peer review model in which authors and reviewers know each other, and it screens submissions for plagiarism该刊采用开放式同行评审模式，作者与审稿人相互知晓身份，并对来稿进行抄袭检测。
• It is published by BMJ on behalf of the First Hospital of Jilin University, and digital copies are archived by Portico and LOCKSS该刊由（BMJ）代表吉林大学第一医院出版，数字版由（Portico）与（LOCKSS）存档。

History

• The journal lists 2023 as its launch date, and the inaugural issue carried an editorial by the founding editors-in-chief Bo-Goran Ericzon, Guoyue Lv and John W. Harmon官方期刊信息将创刊时间列为 2023 年，创刊号刊出创刊主编（Bo-Goran Ericzon）、吕国悦与（John W. Harmon）共同撰写的社论。^[1]
• That editorial announced that all article processing charges would be waived until early 2026 to encourage submissions to the new title该社论宣布为新刊吸引投稿，在 2026 年年初前免除全部文章处理费。
• The founding editors-in-chief served from 2023 to 2025, and the current editors-in-chief are Guoyue Lyu of the First Hospital of Jilin University and Emad El-Omar of the University of New South Wales创刊主编任期为 2023 年至 2025 年，现任主编为吉林大学第一医院的吕国悦与澳大利亚新南威尔士大学（University of New South Wales）的（Emad El-Omar）。^[2]
• Crossref records 25 items for 2023, 33 for 2024 and 36 for 2025, and volumes run one per year from volume 1 in 2023 to volume 4 in 2026（Crossref）记录该刊 2023 年发文 25 篇、2024 年 33 篇、2025 年 36 篇，卷号一年一卷，自 2023 年第 1 卷至 2026 年第 4 卷。
• Its first Journal Impact Factor is 10.5 for 2025, ranking eleventh of one hundred fifty-three titles in Gastroenterology and Hepatology, with a CiteScore of 6.6 and a journal citation indicator of 1.17该刊 2025 年影响因子为 10.5，在胃肠肝病学类 153 种期刊中位列第 11，（CiteScore）为 6.6，期刊引文指标（JCI）为 1.17。
• The journal is indexed in the Web of Science Core Collection through the Emerging Sources Citation Index as well as in PubMed Central, DOAJ and Scopus该刊被（Web of Science）核心合集的新兴来源引文索引（ESCI）以及（PubMed Central）、（DOAJ）与（Scopus）收录。

Editors

• Guoyue Lyu, president of the First Hospital of Jilin University, serves as editor-in-chief, and Emad El-Omar, a former editor-in-chief of Gut, serves as co-editor-in-chief from the University of New South Wales in Australia吉林大学第一医院院长吕国悦任主编之一，澳大利亚新南威尔士大学（University of New South Wales）的（Emad El-Omar）任共同主编，他曾任（Gut）主编。
• The founding editors-in-chief for 2023 to 2025 were Bo-Goran Ericzon of the Karolinska Institutet in Sweden and John W. Harmon of the Johns Hopkins University School of Medicine in the United States2023 年至 2025 年的创刊主编为瑞典卡罗林斯卡医学院（Karolinska Institutet）的（Bo-Goran Ericzon）与美国约翰霍普金斯大学医学院（Johns Hopkins University School of Medicine）的（John W. Harmon）。
• The editorial board numbers 83 people across 15 countries and regions, with the largest contingents in the United States, mainland China and Hong Kong, Germany and Sweden编委会共 83 人，来自 15 个国家和地区，其中美国、中国内地与香港、德国和瑞典人数居前。
• The advisory board brings together the Gut co-editors-in-chief Matias Avila and William Grady alongside the Chinese academicians Jiahong Dong, Jia Fan, Fusheng Wang and Zhigang Tian顾问委员会汇聚了（Gut）共同主编（Matias Avila）与（William Grady），以及董家鸿、樊嘉、王福生、田志刚等中国两院院士。
• Official statistics give a median of five days to first decision without review, twenty-eight days with review and twenty-five days from acceptance to publication官方统计显示投稿至无外审初审决定的中位数为 5 天、含外审为 28 天、接收至发表为 25 天。
• The journal currently charges no article processing fee, and open access articles appear under a CC BY or CC BY-NC license该刊目前不收取文章处理费，开放获取文章以（CC BY）或（CC BY-NC）许可发布。